Records 1 - 4
| Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia.
European journal of clinical pharmacology 2022 Oct 78 (10): 1657-1666.
Zuo Wei, Liu Bo, Chen Miao, Zhang Bo, Han Bi
| Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.
Oncotarget 2018 Feb 9 (10): 9114-9136.
Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E
| Association between ABCG2 and SLCO1B1 polymorphisms and adverse drug reactions to regorafenib: a preliminary study?.
International journal of clinical pharmacology and therapeutics 2017 Feb .
Maeda Akimitsu, Ando Hitoshi, Ura Takashi, Komori Azusa, Hasegawa Ayako, Taniguchi Hiroya, Kadowaki Shigenori, Muro Kei, Tajika Masahiro, Kobara Makiko, Matsuzaki Masahide, Hashimoto Naoya, Maeda Mieko, Kojima Yasushi, Aoki Masahiro, Kondo Eisaku, Mizutani Akiyoshi, Fujimura Ak
| Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients.
Cancer chemotherapy and pharmacology 2013 Oct 72 (4): 825-35.
Kim Hye Ryun, Park Hyung Soon, Kwon Woo Sun, Lee Ji Hyun, Tanigawara Yusuke, Lim Sun Min, Kim Hyo Song, Shin Sang Jun, Ahn Jung Bae, Rha Sun You